Comparison of Valve Annuloplasty and Replacement for Ischemic Mitral Valve Incompetence
DOI:
https://doi.org/10.1532/HSF98.20081087Abstract
Objective: Mitral incompetence is a chronic sequela of myocardial infarction. It is caused by apical displacement and tethering of the mitral valve leaflets after myocardial infarction, resulting in incomplete coaptation. The consensus is for mitral valve surgery in the presence of significant ischemic mitral regurgitation (IMR). Previously, the only option was mitral valve replacement (MVR) with a mechanical or tissue valve. The suboptimal results obtained prompted the development of several methods of mitral valve repair. Today, the most commonly used repair is undersized annuloplasty.
Methods: We conducted a retrospective nonrandomized study of all patients who underwent operation for coronary artery disease and IMR between 2000 and 2006. The surgeon chose the surgical method used for the mitral valve procedure. The most commonly used procedures were restrictive mitral valve annuloplasty (MVP) and MVR with a mechanical prosthesis. We collected all pertinent preoperative, intraoperative, and early-postoperative data. We followed up with phone interviews of the patients and their relatives and with complete clinical and echocardiography examinations.
Results: We carried out operations on 138 patients during the study period (MVR, 52 patients; MVP, 86 patients). The 2 groups had comparable demographic data and risk factors. The 2 groups were significantly different with respect to mean (±SD) New York Heart Association (NYHA) class (MVP, 2.72 ± 0.62; MVR, 2.48 ± 0.70; P < .01) and ejection fraction (MVP, 29.01% ± 11.00%; MVR, 35.87% ± 11.00%; P ? .01). The 30-day mortality rates for the MVR and MVP groups were significantly different (9.61% and 5.81%, respectively; P < .01). Our follow-up included 83% of the patients and continued for up to 84 months. The 2 groups showed no significant difference in mortality by the end of follow-up; however, the MVR patients had a better ejection fraction (37.79% versus 29.86%) and NYHA functional class (1.88 ± 0.498 versus 2.36 ± 0.564; P < .01).
Conclusion: Correcting chronic IMR with either repair or replacement produces a good mid-term survival rate (approximately 75%) for survivors in NYHA classes I and II. In our study, mortality rates for the MVP and MVR groups were similar, even though the repair group had a lower mean ejection fraction and a higher NYHA class before and after the operation. We therefore conclude that repair is superior to replacement in treating ischemic mitral insufficiency. A prospective randomized study is needed to better compare these 2 approaches.
References
Al-Radi OO, Austin PC, Tu JV, David TE, Yau TM. 2005. Mitral repair versus replacement for ischemic mitral regurgitation. Ann Thorac Surg 79:1260-7.nBishay ES, McCarthy PM, Cosgrove PM, et al. 2000. Mitral valve surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg 17:213-21.nBolling SF, Pagani FD, Deeb GM, Bach DS. 1998. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115:381-8.nCalafiore AM, Di Mauro M, Gallina S, et al. 2004. Mitral valve surgery for chronic ischemic mitral regurgitation. Ann Thorac Surg 77:1989-97.nCalafiore AM, Gallina S, Di Mauro M, et al. 2001. Mitral valve procedure in dilated cardiomyopathy: repair or replacement? Ann Thorac Surg 71:1146-53.nCarabello B. 2000. The pathophysiology of mitral regurgitation. J Heart Valve Dis 9:600-8.nCarpentier A, Chauvaud S, Fabiani JN, et al. 1980. Reconstructive surgery of mitral valve incompetence. J Thorac Cardiovasc Surg 79:338-48.nGillinov AM, Wierup PN, Blackstone EH, et al. 2001. Is repair preferable for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 122:1125-41.nGorman RC, Gorman JH III, Edmunds LH Jr. 2003. Ischemic mitral regurgitation. In: Cohn LH, Edmunds LH Jr, eds. Cardiac surgery in the adult. New York, NY: McGraw-Hill. p 751-69.nGrossi EA, Goldberg JD, LaPietra A, et al. 2001. Ischemic mitral valve reconstruction and replacement comparison of long-term survival and complications. J Thorac Cardiovasc Surg 122:1107-24.nHausmann H, Siniawski H, Hotz H, et al. 1997. Mitral reconstruction and mitral valve replacement for ischemic mitral insufficiency. J Card Surg 12:8-14.nHendren WG, Nemec JJ, Lytle BW, et al. 1991. Mitral valve repair for ischemic mitral insufficiency. Ann Thorac Surg 52:1246-52.nHung J, Papakostas L, Tahta SA, et al. 2004. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty: continued LV remodeling as a moving target. Circulation 110(suppl 1):II85-90.nIung B. 2003. Management of ischaemic mitral regurgitation. Heart 89:459-64.nJamieson WRE, Cartier PC, Allard M, et al. 2004. Canadian Cardiovascular Consensus 2004: surgical management of valvular heart disease. Can J Cardiol 20(suppl E):33E-49E.nKumanohoso T, Otsuji Y, Yoshifuku S, et al. 2003. Mechanism of higher incidence of ischemic mitral regurgitation in patients with inferior myocardial infarction quantitative analysis of left ventricular and mitral valve geometry in 103 patients with prior myocardial infarction. J Thorac Cardiovasc Surg 125:135-43.nLam BK, Gillinov AM, Blackstone EH, et al. 2005. Importance of moderate ischemic mitral regurgitation. Ann Thorac Surg 79:462-70.nLiel-Cohen N, Otsuji Y, Vlahakes GJ. 1997. Functional ischemic mitral regurgitation can persist despite ring annuloplasty: mechanistic insights. Circulation 96(suppl):I540.nMcGee EC, Gillinov AM, Blackstone EH, et al. 2004. Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128:916-24.nMiller DC. 2004. The three-dimensional geometry of the mitral valve: implications for surgical therapy. In: Proceedings of the 84th Annual Meeting of the American Association for Thoracic Surgery, Toronto, Ontario, Canada.nMiller DC. Ischemic mitral regurgitation redux: to repair or to replace? 2000. J Thorac Cardiovasc Surg 122:159-62.nRumberger JA. 1994. Ventricular dilatation and remodeling after myocardial infarction. Mayo Clin Proc 64:664-74.nTcheng JE, Jackman JD Jr, Nelson CL, et al. 1992. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 117:18-24.n
